Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate
Greater Pennsylvania
Change Location

LECOM Health named Presenting Sponsor of the 2022 Erie Walk to End Alzheimer’s

LECOM Health named Presenting Sponsor of the 2022 Erie Walk to End Alzheimer’s
Share or Print this page
Share or Print this page
April 8, 2022
Email: bgrego@alz.org
Share or Print this page
FOR IMMEDIATE RELEASE:                            
Contact: Brittany Grego 724-413-6967, bgrego@alz.org
                                                                                               

LECOM Health named Presenting Sponsor
of the 2022 Erie Walk to End Alzheimer’s

 

Health system donates $15,000 toward the fight
to end Alzheimer’s and all other dementia

 
ERIE, PA, April 8, 2022 – The Alzheimer’s Association of Greater Pennsylvania is pleased to announce LECOM Health as the 2022 presenting sponsor for the Erie Walk to End Alzheimer’s to be held on September 24, 2022 in Perry Square. LECOM Health has made a gift of $15,000 to support the mission of the Alzheimer’s Association.
 
The Alzheimer’s Association Walk to End Alzheimer’s  is the world’s largest event dedicated to Alzheimer’s care, support and research. On Walk day, participants honor those affected by Alzheimer’s with the poignant Promise Garden ceremony — a mission-focused experience that signifies our solidarity in the fight against the disease. The colors of the Promise Garden flowers represent people’s connection to Alzheimer’s — their personal reasons to end the disease.
 
“LECOM Health is an academic health system focused on helping to bring a lifetime of wellness to those who matter most to you,” said John M. Ferretti, D.O., President of Lake Erie College of Osteopathic Medicine. “Our specialists, primary care physicians and staff are proud to join in the fight against Alzheimer’s and promote awareness of the disease.”
 
“The Alzheimer’s Association draws hundreds of walkers and teams to the event each fall and it is a pivotal event to spread community awareness and concern for Alzheimer’s disease,” said Sara Giammarise, Walk Director for the Alzheimer’s Association Greater Pennsylvania Chapter. “LECOM Health’s presenting sponsorship will allow us to increase our work in the community, reach more families affected, advocate for policy change and ultimately help us find a cure for this disease. Corporate involvement is an absolute must and LECOM Health has set the bar high this year.”
 
More than 6 million Americans are living with Alzheimer's disease – a leading cause of death in the United States. Additionally, more than 11 million family members and friends provide care to people living with Alzheimer’s and other dementias. In Pennsylvania alone, there are more than 280,000 people living with the disease and over 500,000 caregivers. 
 
To register and receive the latest updates on this year’s Walk to End Alzheimer’s, visit act.alz.org/erie2022.
 
Alzheimer's Association Walk to End Alzheimer’s®
The Alzheimer’s Association Walk to End Alzheimer’s  is the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research.  Since 1989, the Alzheimer’s Association mobilized millions of Americans in the Alzheimer’s Association Memory Walk®; now the Alzheimer’s Association is continuing to lead the way with Walk to End Alzheimer’s. Together, we can end Alzheimer’s.  
 

Alzheimer's Association

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.

Keep Up With Alzheimer’s News and Events

The first survivor of Alzheimer's is out there, but we won't get there without you.

Donate Now

Learn how Alzheimer’s disease affects the brain.

Take the Brain Tour

Don't just hope for a cure. Help us find one. Volunteer for a
clinical trial.

Learn More